Small for Gestational Age Infant Clinical Trial
Official title:
Phase Ⅲ Clinical Study of Recombinant Human Growth Hormone Injection (JINTOPIN AQ) for Short Children With Small for Gestational Age(SGA)
According to the results of the phase II study, choose the best dose of JINTOPIN AQ for short SGA children, further to evaluate the efficacy and safety of the treatment of short SGA children.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05059093 -
Developing and Testing AI Models for Fetal Biometry and Amniotic Volume Assessment in Fetal Ultrasound Scans.
|
||
Recruiting |
NCT02375620 -
Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short Stature
|
Phase 2 | |
Not yet recruiting |
NCT05043753 -
"Fetal gRowth AbnorMality dEtection Trial"
|
N/A | |
Not yet recruiting |
NCT05070234 -
Genetic Diagnosis and Human Growth Hormone Treatment in Small for Gestational Age Children With Short Stature
|
||
Active, not recruiting |
NCT05343403 -
Parental Participation on the Neonatal Ward - the neoPARTNER Study
|
||
Not yet recruiting |
NCT05436119 -
Select Nutrient and Gene Variant Analysis in a Targeted Diet and Lifestyle Intervention Reduces Preterm Birth
|
||
Recruiting |
NCT04315545 -
Pregnancy Outcomes and Maternal Insulin Sensitivity
|
||
Completed |
NCT03221933 -
A Study of Recombinant Human Growth Hormone Injection(JINTOPIN AQ)for Short Children With Small for SGA
|
Phase 2 | |
Not yet recruiting |
NCT04050488 -
Zinc Supplementation on Very Low Birth Weight Infant
|
Phase 4 | |
Recruiting |
NCT05144035 -
A Real World Study of the Effect of Early PEG-rhGH Therapy on Cognitive Development of SGA Infants
|
Phase 4 |